Literature DB >> 24018384

The ins and outs of hepatitis C virus entry and assembly.

Brett D Lindenbach1, Charles M Rice.   

Abstract

Hepatitis C virus, a major human pathogen, produces infectious virus particles with several unique features, such as an ability to interact with serum lipoproteins, a dizzyingly complicated process of virus entry, and a pathway of virus assembly and release that is closely linked to lipoprotein secretion. Here, we review these unique features, with an emphasis on recent discoveries concerning virus particle structure, virus entry and virus particle assembly and release.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24018384      PMCID： PMC3897199          DOI： 10.1038/nrmicro3098

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN： 1740-1526            Impact factor:   60.633


  161 in total

1.  EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.

Authors:  Joachim Lupberger; Mirjam B Zeisel; Fei Xiao; Christine Thumann; Isabel Fofana; Laetitia Zona; Christopher Davis; Christopher J Mee; Marine Turek; Sebastian Gorke; Cathy Royer; Benoit Fischer; Muhammad N Zahid; Dimitri Lavillette; Judith Fresquet; François-Loïc Cosset; S Michael Rothenberg; Thomas Pietschmann; Arvind H Patel; Patrick Pessaux; Michel Doffoël; Wolfgang Raffelsberger; Olivier Poch; Jane A McKeating; Laurent Brino; Thomas F Baumert
Journal:  Nat Med       Date:  2011-04-24       Impact factor: 53.440

2.  Structure-function analysis of hepatitis C virus envelope-CD81 binding.

Authors:  R Petracca; F Falugi; G Galli; N Norais; D Rosa; S Campagnoli; V Burgio; E Di Stasio; B Giardina; M Houghton; S Abrignani; G Grandi
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein.

Authors:  M Flint; J Dubuisson; C Maidens; R Harrop; G R Guile; P Borrow; J A McKeating
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.

Authors:  V Agnello; G Abel; M Elfahal; G B Knight; Q X Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 5.  Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus.

Authors:  K Morikawa; C M Lange; J Gouttenoire; E Meylan; V Brass; F Penin; D Moradpour
Journal:  J Viral Hepat       Date:  2011-03-23       Impact factor: 3.728

6.  Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry.

Authors:  Donna M Tscherne; Christopher T Jones; Matthew J Evans; Brett D Lindenbach; Jane A McKeating; Charles M Rice
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

7.  NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly.

Authors:  Costin-Ioan Popescu; Nathalie Callens; Dave Trinel; Philippe Roingeard; Darius Moradpour; Véronique Descamps; Gilles Duverlie; François Penin; Laurent Héliot; Yves Rouillé; Jean Dubuisson
Journal:  PLoS Pathog       Date:  2011-02-10       Impact factor: 6.823

8.  Regulation of hepatitis C virion production via phosphorylation of the NS5A protein.

Authors:  Timothy L Tellinghuisen; Katie L Foss; Jason Treadaway
Journal:  PLoS Pathog       Date:  2008-03-21       Impact factor: 6.823

Review 9.  Virus membrane-fusion proteins: more than one way to make a hairpin.

Authors:  Margaret Kielian; Félix A Rey
Journal:  Nat Rev Microbiol       Date:  2006-01       Impact factor: 60.633

10.  Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro.

Authors:  Brett D Lindenbach; Philip Meuleman; Alexander Ploss; Thomas Vanwolleghem; Andrew J Syder; Jane A McKeating; Robert E Lanford; Stephen M Feinstone; Marian E Major; Geert Leroux-Roels; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-16       Impact factor: 11.205
View more
  161 in total

1.  A Novel Approach To Display Structural Proteins of Hepatitis C Virus Quasispecies in Patients Reveals a Key Role of E2 HVR1 in Viral Evolution.

Authors:  Yimin Tong; Qingchao Li; Rui Li; Yongfen Xu; Yu Pan; Junqi Niu; Jin Zhong
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  Characterization of type I interferon pathway during hepatic differentiation of human pluripotent stem cells and hepatitis C virus infection.

Authors:  Joseph Ignatius Irudayam; Deisy Contreras; Lindsay Spurka; Aparna Subramanian; Jenieke Allen; Songyang Ren; Vidhya Kanagavel; Quoclinh Nguyen; Arunachalam Ramaiah; Kalidas Ramamoorthy; Samuel W French; Andrew S Klein; Vincent Funari; Vaithilingaraja Arumugaswami
Journal:  Stem Cell Res       Date:  2015-08-15       Impact factor: 2.020

3.  Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus.

Authors:  Holly Freedman; Michael R Logan; Darren Hockman; Julia Koehler Leman; John Lok Man Law; Michael Houghton
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

4.  A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I.

Authors:  Adam Zuiani; Kevin Chen; Megan C Schwarz; James P White; Vincent C Luca; Daved H Fremont; David Wang; Matthew J Evans; Michael S Diamond
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

5.  Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo.

Authors:  George Koutsoudakis; Alexia Paris de León; Carolina Herrera; Marcus Dorner; Gemma Pérez-Vilaró; Sébastien Lyonnais; Santiago Grijalvo; Ramon Eritja; Andreas Meyerhans; Gilles Mirambeau; Juana Díez
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

6.  Altered Glycosylation Patterns Increase Immunogenicity of a Subunit Hepatitis C Virus Vaccine, Inducing Neutralizing Antibodies Which Confer Protection in Mice.

Authors:  Dapeng Li; Markus von Schaewen; Xuesong Wang; Wanyin Tao; Yunfang Zhang; Li Li; Brigitte Heller; Gabriela Hrebikova; Qiang Deng; Alexander Ploss; Jin Zhong; Zhong Huang
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

7.  Editorial on "Broadly neutralizing antibodies abrogate established hepatitis C virus infection" published in Science Translational Medicine on 17th September 2014.

Authors:  Heidi E Drummer
Journal:  Ann Transl Med       Date:  2015-05

Review 8.  Immune responses to HCV and other hepatitis viruses.

Authors:  Su-Hyung Park; Barbara Rehermann
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

Review 9.  Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade.

Authors:  Heidi Barth
Journal:  World J Hepatol       Date:  2015-04-18

Review 10.  Hunting Viral Receptors Using Haploid Cells.

Authors:  Sirika Pillay; Jan E Carette
Journal:  Annu Rev Virol       Date:  2015-07-02       Impact factor: 10.431
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.